USA – The future of USAID, the world’s largest provider of humanitarian aid, is facing serious doubts. The organization, known for its efforts to improve medicine quality and safety in low- and middle-income countries, may be shut down and merged into the US State Department. Over the weekend, its website went offline, fueling rumors about […]
JAPAN – Daiichi Sankyo has announced that Hiroyuki Okuzawa, the current Chief Operating Officer (COO), will take over as Chief Executive Officer (CEO) starting April 1, 2025. Okuzawa, a long-time executive with the company, will replace Sunao Manabe, who has held the CEO position since 2019 and will transition to the role of executive chairperson. […]
FRANCE – Global diagnostics company bioMérieux has acquired SpinChip Diagnostics ASA, a Norwegian firm known for its groundbreaking immunoassay platform. The small, benchtop analyzer developed by SpinChip can deliver lab-quality results from whole blood samples in under 10 minutes, making it ideal for near-patient testing. This innovation aims to improve acute care, particularly in diagnosing […]
GERMANY – Bayer has submitted its drug finerenone for approval in the European Union as a treatment for heart failure in patients with mildly reduced or preserved left ventricular ejection fraction (HFmrEF or HFpEF). This marks a key milestone in Bayer’s 2025 pipeline goals. The company had previously filed for approval of the same use […]
U.K. – The National Health Service (NHS) in England has approved Vertex Pharmaceuticals’ groundbreaking gene-editing therapy, Casgevy, for sickle cell disease (SCD) under a managed access scheme with a confidential discount. This therapy, priced at £1.65 million (US $2.05 million), offers hope to patients aged 12 and older who experience at least two vaso-occlusive crises […]
U.K. – In a surprising decision, AstraZeneca (AZ) has canceled its £450 million (US $558 million) plan to build a vaccine manufacturing plant in Liverpool, UK. The move comes after the UK government reduced its financial support for the project. According to an AZ spokesperson, the decision was influenced by “several factors […] including the […]
USA – Amplitude Vascular Systems (AVS), a Boston-based company specializing in medical devices, has raised US $36 million in a Series B funding round. The funds will be used to advance clinical trials and prepare for the U.S. launch of the company’s innovative Pulse IVL platform. “We are pleased to see strong, sustained investor excitement […]
FRANCE – Sanofi has reported an 11.3% increase in sales for 2024, with total revenue reaching €41 billion (US $42.7 billion). This growth was largely fueled by the performance of its autoimmune therapy, Dupixent, which generated €13 billion (US $13.62 billion) in sales. However, analysts at BMO Capital Markets noted that this fell slightly short […]
FRANCE – Owkin, a leading AI-driven biotechnology company, has taken a major step in its drug development efforts. On January 22, 2025, the company dosed its first patient in the Phase I clinical trial of OKN4395, a groundbreaking drug that introduces a novel triple inhibition mechanism targeting EP2, EP4, and DP1 receptors. These receptors are […]
SWITZERLAND – Novartis, one of the most active pharmaceutical dealmakers in 2024, plans to maintain its momentum this year with additional bolt-on acquisitions aimed at long-term growth. Speaking during a media call on Friday, CEO Vas Narasimhan confirmed the company’s commitment to strategic deals that enhance its future pipeline. “We will continue our strategy to […]
NETHERLANDS – The European Medicines Agency (EMA) has decided to stop posting updates on X.com, formerly known as Twitter, and will instead move its communication efforts to the rapidly growing platform Bluesky. The agency announced, “EMA will no longer post updates and content on X. We believe the X platform no longer suits our communication […]
USA – Metsera and Maze Therapeutics have become the second and third biotech companies this year to go public, collectively raising US $415 million in initial public offerings (IPOs). Metsera, which focuses on obesity treatments, raised US $275 million by selling approximately 15.3 million shares at US $18 each. Maze, a company developing kidney disease […]
XRP HEALTHCARE L.L.C | License Number: 2312867.01 | Dubai | © Copyright 2025 | All Rights Reserved